Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies

Journal of Medical Virology

Volumn 80, Issue 3, 2008, Pages 411-418

  Muerhoff, A Scott ^a,b   Gutierrez, Robin ^a   Kyrk, Charles ^a   Leary, Thomas ^a   Schlauder, George ^a   Dawson, George ^a   Desai, Suresh M ^a  

^a ABBOTT LABORATORIES   (United States)

^b Bldg AP20 4 ^*  (United States)

Author keywords

Immunodominant; Nucleocapsid; Sequence divergence

Indexed keywords

PEPTIDE; RECOMBINANT PROTEIN; VIRUS ANTIBODY;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANTIBODY DETECTION; ARTICLE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; NONHUMAN; VIRUS ISOLATION;

AMINO ACID SEQUENCE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; MOLECULAR SEQUENCE DATA; PEPTIDES; SEQUENCE ALIGNMENT; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 38849137281     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21082     Document Type: Article

References (30)

1. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ. 1991. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first-and second-generation assays. N Engl J Med 325:1325-1329.
2. Alter HJ. 1992. New kit on the block: Evaluation of second-generation assays for detection of antibody to the hepatitis C virus. Hepatology 15:350-353.
3. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G. 1989. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321:1494-1500.
4. Beld M, Penning M, van Putten M, Lukashov V, van den Hoek A, McMorrow M, Goudsmit J. 1999. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood. Hepatology 29:1288-1298.
5. Bresters D, Cuypers HT, Reesink HW, Schaasberg WP, van der Poel CL, Mauser-Bunschoten EP, Houghton M, Choo QL, Kuo G, Lesniewski R, Troohen H, Lelie PN. 1992. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus. Vox Sang 62: 213-217.
6. Callahan JD, Constantine NT, Kataaha P, Zhang X, Hyams KC, Bansal J. 1993. Second generation hepatitis C virus assays: Performance when testing African sera. J Med Virol 41:35-38.
7. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
8. Courouce AM, Le Marrec N, Girault A, Ducamp S, Simon N. 1994. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: Comparison of second- and third-generation anti-HCV assays. Transfusion 34:790-795.
9. Dhaliwal SK, Prescott LE, Dow BC, Davidson F, Brown H, Yap PL, Follett EA, Simmonds P. 1996. Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. J Med Virol 48:184-190.
10. Dow BC, Buchanan I, Munro H, Follett EA, Davidson F, Prescott LE, Yap PL, Simmonds P. 1996. Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors. J Med Virol 49:132-136.
11. El Awady MK, El-Demellawy MA, Khalil SB, Galal D, Goueli SA. 2002. Synthetic peptide-based immunoassay as a supplemental test for HCV infection. Clin Chim Acta 325:39-46.
12. Halfon P, Bourliere M, Khiri H, Halimi G, Gerolami V, Feryn JM, Ouzan D. 2002. Serological response to infection with different isolates of hepatitis C virus. J Viral Hepat 9:438-442.
13. Hino K. 1994. Diagnosis of hepatitis C. Intervirology 37:77-86.
14. Kleinman S, Alter H, Busch M, Holland P, Tegtmeier G, Nelles M, Lee S, Page E, Wilber J, Polito A. 1992. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 32:805-813.
15. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, et al. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
16. Laperche S, Elghouzzi MH, Morel P, Asso-Bonnet M, Le Marrec N, Girault A, Servant-Delmas A, Bouchardeau F, Deschaseaux M, Piquet Y. 2005. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing? Transfusion 45:1965-1972.
17. Lee SR, Wood CL, Lane MJ, Francis B, Gust C, Higgs CM, Nelles MJ, Polito A, DiNello R, Achord D. 1995. Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay [see comments]. Transfusion 35:845-849.
18. Leon P, Lopez JA, Elola C, Lee SR, Calmann M, Echevarria JM. 1998. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen. Vox Sang 75:32-36.
19. Machida A, Ohnuma H, Tsuda F, Munekata E, Tanaka T, Akahane Y, Okamoto H, Mishiro S. 1992. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology 16:886-891.
20. Mimms L, Vallari D, Ducharme L, Holland P, Kuramoto IK, Zeldis J. 1990. Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions. Lancet 336:1590-1591.
21. Nagayama R, Tsuda F, Okamoto H, Wang Y, Mitsui T, Tanaka T, Miyakawa Y, Mayumi M. 1993. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-protein. J Clin Invest 92:1529-1533.
22. Neville JA, Prescott LE, Bhattacherjee V, Adams N, Pike I, Rodgers B, El-Zayadi A, Hamid S, Dusheiko GM, Saeed AA, Haydon GH, Simmonds P. 1997. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus. J Clin Microbiol 35:3062-3070.
23. Sallberg M, Ruden U, Wahren B, Magnius LO. 1992. Immunodominant regions within the hepatitis C virus core and putative matrix proteins. J Clin Microbiol 30:1989-1994.
24. Sallberg M, Pumpen P, Zhang ZX, Lundholm P, Gusars I, Ruden U, Wahren B, Magnius LO. 1994. Locations of antibody binding sites within conserved regions of the hepatitis C virus core protein. J Med Virol 43:62-68.
25. Sato A, Sho Y, Nakamura H, Kunitomo T, Arima T. 1994. Immune responses of blood donors to peptides of various lengths and those with genotypic sequence variations corresponding to the N-terminal portion of the core protein of hepatitis C virus. J Med Virol 44:88-91.
26. Shah DO, Chang CD, Jiang LX, Cheng KY, Muerhoff AS, Gutierrez RA, Leary TP, Desai SM, Batac-Herman IV, Salbilla VA, Haller AS, Stewart JL, Dawson GJ. 2003. Combination HCV core antigen and antibody assay on a fully automated chemiluminescence analyzer. Transfusion 43:1067-1074.
27. Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, Follett EA, Yap PL, Marsden H. 1993. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2,and 3. J Clin Microbiol 31:1493-1503.
28. Simmonds P, Smith DB, McOmish F, Yap PL, Kolberg J, Urdea MS, Holmes EC. 1994. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol 75:1053-1061.
29. Tobler LH, Lee SR, Stramer SL, Peterson J, Kochesky R, Watanabe K, Quan S, Polito A, Busch MP. 2000. Performance of second- and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations. Retrovirus Epidemiology Donor Study. Transfusion 40:917-923.
30. Zein NN, Germer JJ, Wendt NK, Schimek CM, Thorvilson JN, Mitchell PS, Persing DH. 1997. Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: Significance of high-level c 22-3reactivity and influence of HCV genotypes. J Clin Microbiol 35:311-312.